Benefit of combined extracorporeal shock wave and bone marrow-derived endothelial progenitor cells in protection against critical limb ischemia in rats

Critical Care Medicine

Volumn 40, Issue 1, 2012, Pages 169-177

  Yeh, Kuo Ho ^a   Sheu, Jiunn Jye ^a   Lin, Yu Chun ^a   Sun, Cheuk Kwan ^a   Chang, Li Teh ^b   Kao, Ying Hsien ^c   Yen, Chia Hong ^d   Shao, Pei Lin ^e   Tsai, Tzu Hsien ^a   Chen, Yung Lung ^a   Chua, Sarah ^a   Leu, Steve ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b MEIHO UNIVERSITY   (Taiwan)

^c I SHOU UNIVERSITY   (Taiwan)

^d NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Critical limb ischemia; Endothelial progenitor cells; Extracorporeal shock wave

Indexed keywords

ACTIN; CASPASE 3; CD31 ANTIGEN; CHEMOKINE RECEPTOR CCR4; CONNEXIN 43; CYTOCHROME C; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GELATINASE B; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEIN BAX; PROTEIN BCL 2; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW; BONE MARROW; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; CULTURE MEDIUM; ENDOTHELIAL PROGENITOR CELL; EXTRACORPOREAL LITHOTRIPSY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MALE; MITOCHONDRION; NONHUMAN; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; RAT; SHAM PROCEDURE;

ANIMALS; BLOTTING, WESTERN; CONNEXIN 43; ENDOTHELIAL CELLS; EXTREMITIES; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HIGH-ENERGY SHOCK WAVES; INTERLEUKIN-10; ISCHEMIA; MALE; MATRIX METALLOPROTEINASE 9; NITRIC OXIDE SYNTHASE TYPE III; PLASMINOGEN ACTIVATOR INHIBITOR 1; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; REGIONAL BLOOD FLOW; TRANSFORMING GROWTH FACTOR BETA;

EID: 84055166928     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31822d74d0     Document Type: Article

References (29)

1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286:1317-1324
2. Ouriel K: Peripheral arterial disease. Lancet 2001; 358:1257-1264
3. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362:801-809
4. van der Wal AC, Becker AE, van der Loos CM, et al: Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89:36-44
5. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126
6. Yip HK, Wu CJ, Chang HW, et al: Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest 2004; 126:1417-1422
7. Yip HK, Wu CJ, Yang CH, et al: Serial changes in circulating concentrations of soluble CD40 ligand and C-reactive protein in patients with unstable angina undergoing coronary stenting. Circ J 2005; 69:890-895
8. Cooke JP: The pathophysiology of peripheral arterial disease: Rational targets for drug intervention. Vasc Med 1997; 2:227-230
9. Wu WC, Mohler E 3rd, Ratcliffe SJ, et al: Skeletal muscle microvascular flow in progressive peripheral artery disease: Assessment with continuous arterial spin-labeling perfusion magnetic resonance imaging. J Am Coll Cardiol 2009; 53:2372-2377
10. Ghani U, Shuaib A, Salam A, et al: Endothelial progenitor cells during cerebrovascular disease. Stroke 2005; 36:151-153
11. Kalka C, Masuda H, Takahashi T, et al: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97:3422-3427
12. Saltzman AJ, Choi SW, Dabreo A, et al: Endothelial progenitor cells delivered into the pericardial space incorporate into areas of ischemic myocardium. Cardiovasc Revasc Med 2010; 11:241-248
13. Yu JX, Huang XF, Lv WM, et al: Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified en-dothelial progenitor cells is more effective for ischemic neovascularization. J Vasc Surg 2009; 50:608-616
14. Gutersohn A, Gaspari G: Shock waves upregulate vascular endothelial growth factor mRNA in human umbilical vascular endothelial cells. Circulation 2000; 102(suppl):18
15. Yip HK, Chang LT, Sun CK, et al: Shock wave therapy applied to rat bone marrow-derived mononuclear cells enhances formation of cells stained positive for CD31 and vascular endothelial growth factor. Circ J 2008; 72:150-156
16. Wang CJ, Wang FS, Yang KD, et al: Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res 2003; 21:984-989
17. Chen YJ, Wurtz T, Wang CJ, et al: Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res 2004; 22:526-534
18. Aicher A, Heeschen C, Sasaki K, et al: Lowenergy shock wave for enhancing recruitment of endothelial progenitor cells: A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006; 114:2823-2830
19. Amann B, Luedemann C, Ratei R, et al: Autologous bone marrow cell transplantation increases leg perfusion and reduces amputations in patients with advanced critical limb ischemia due to peripheral artery disease. Cell Transplant 2009; 18: 371-380
20. Shao PL, Chiu CC, Yuen CM, et al: Shock wave therapy effectively attenuates inflammation in rat carotid artery following endothelial denudation by balloon catheter. Cardiology 2010; 115:130-144
21. Yip HK, Chang LT, Sun CK, et al: Autologous transplantation of bone marrow-derived endothelial progenitor cells attenuates monocrotaline-induced pulmonary arterial hypertension in rats. Crit Care Med 2008; 36: 873-880
22. Sun CK, Chang LT, Sheu JJ, et al: Bone marrow-derived mononuclear cell therapy alleviates left ventricular remodeling and improves heart function in rat-dilated cardiomyopathy. Crit Care Med 2009; 37:1197-1205
23. Hu Z, Zhang F, Yang Z, et al: Combination of simvastatin administration and EPC transplantation enhances angiogenesis and protects against apoptosis for hindlimb ischemia. J Biomed Sci 2008; 15:509-517
24. Lara-Hernandez R, Lozano-Vilardell P, Blanes P, et al: Safety and efficacy of therapeutic angiogenesis as a novel treatment in patients with critical limb ischemia. Ann Vasc Surg 2010; 24:287-294
25. Kolvenbach R, Kreissig C, Ludwig E, et al: Stem cell use in critical limb ischemia. J Cardiovasc Surg 2007; 48:39-44
26. Nishida T, Shimokawa H, Oi K, et al: Extracorporeal cardiac shock wave therapy markedly ameliorates ischemia-induced myocardial dysfunction in pigs in vivo. Circulation 2004; 110:3055-3061
27. Kuo YR, Wu WS, Hsieh YL, et al: Extracorporeal shock wave enhanced extended skin flap tissue survival via increase of topical blood perfusion and associated with suppression of tissue proinflammation. J Surg Res 2007; 143:385-392
28. Thum T, Bauersachs J, Poole-Wilson PA, et al: The dying stem cell hypothesis: Immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. J Am Coll Cardiol 2005; 46:1799-1802
29. Lin YC, Leu S, Sun CK, et al: Early combined treatment with sildenafil and adipose-derived mesenchymal stem cells preserves heart function in rat dilated cardiomyopathy. J Transl Med 2010; 8:88